Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety Testing

Author： Kasper Peter Oliver Gerry Lima Beatriz Silva Singer Thomas Tweats David

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.2, 2005-03, pp. : 181-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Report on the joint EFPIA, DIA and EMEA pharmacogenetics workshop: moving toward clinical application

By McCarthy A Kerr M Abadie E Chibout S-D Imbert G Cohen N Drakoulis N Knudsen LE Flamion B Hashimoto L Kreutz W Verhoofstad G McHale D Mitchell T Papaluca Amati M Roberts R Shaw P Stuerzebecher CS Townend D

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 731-739

Future Medicine

Access to resources Recommend Favorite

Non-Clinical Development of Fixed Combinations: A European Regulatory Perspective

By Ulla Liminga Beatriz Silva Lima

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. : 135-138

Adis International

Access to resources Recommend Favorite

CHMP opinions on safety variations

Reactions Weekly, Vol. 1, Iss. 1391, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Injecting eye‐drops: a mini‐review on the non‐clinical use of tropicamide

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 4, 2015-07 ,pp. : 262-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologics Safety Preclinical, Clinical and Regulatory

By Hennig Renald

Expert Opinion on Drug Safety, Vol. 2, Iss. 6, 2003-11 ,pp. : 609-611

Informa Healthcare

Access to resources Recommend Favorite